Hall Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,429
Closed -$263K 82
2019
Q2
$263K Sell
1,429
-3,523
-71% -$631K 0.22% 75
2019
Q1
$941K Buy
4,952
+265
+6% +$50.6K 0.82% 45
2018
Q4
$912K Buy
4,687
+420
+10% +$81.9K 0.91% 43
2018
Q3
$885K Buy
4,267
+179
+4% +$35.3K 0.77% 46
2018
Q2
$755K Buy
4,088
+40
+1% +$7.08K 0.71% 45
2018
Q1
$690K Buy
4,048
+57
+1% +$10.5K 0.66% 48
2017
Q4
$694K Buy
3,991
+50
+1% +$8.85K 0.61% 50
2017
Q3
$735K Buy
3,941
+85
+2% +$15.1K 0.68% 47
2017
Q2
$664K Buy
3,856
+1,215
+46% +$198K 0.62% 50
2017
Q1
$433K Buy
2,641
+135
+5% +$22.4K 0.41% 59
2016
Q4
$366K Buy
+2,506
New +$377K 0.36% 61
2015
Q3
$260K Sell
1,886
-130
-6% -$20.5K 0.31% 64
2015
Q2
$309K Sell
2,016
-1,170
-37% -$187K 0.35% 65
2015
Q1
$509K Sell
3,186
-5
-0.2% -$787 0.53% 57
2014
Q4
$508K Buy
+3,191
New +$497K 0.52% 55

Other funds holding AMGN

Hall Capital Management's AMGN Position: Q3 2019 in Review

Hall Capital Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 1,429 shares — an estimated $263K sold.

Hall Capital Management first reported a position in AMGN in Q4 2014 and held it in 15 quarters. The position peaked at $941K in Q1 2019. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Hall Capital Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Hall Capital Management sold 1,429 Amgen shares in Q3 2019, an estimated $263K.
  • Hall Capital Management first reported a position in Amgen in Q4 2014 and held it in 15 quarters.
  • Hall Capital Management's Amgen position peaked at $941K in Q1 2019.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Hall Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.